北陆药业（300016.SZ）在互动平台称，公司碘帕醇注射液已通过仿制药一致性评价。
智通财经直播 · 02/21/2022 08:16
Share
Listen to the news
北陆药业（300016.SZ）在互动平台称，公司碘帕醇注射液已通过仿制药一致性评价。
北陆药业（300016.SZ）在互动平台称，公司碘帕醇注射液已通过仿制药一致性评价。
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
Share your ideas here…
All Comments
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2025 Webull. All Rights Reserved